BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 34 filers reported holding BRIDGEBIO PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,039,375 | +257.6% | 21,875,000 | +191.7% | 0.87% | +237.5% |
| Q2 2023 | $5,882,850 | +25849.9% | 7,500,000 | -75.3% | 0.26% | -68.9% |
| Q1 2023 | $22,670 | +20.5% | 30,329,000 | -35.9% | 0.83% | +60.8% |
| Q4 2022 | $18,813 | -99.9% | 47,329,000 | +2.4% | 0.52% | +35.6% |
| Q3 2022 | $27,183,000 | +12.3% | 46,229,000 | 0.0% | 0.38% | -30.7% |
| Q2 2022 | $24,197,000 | -16.4% | 46,229,000 | -6.1% | 0.55% | -18.1% |
| Q1 2022 | $28,932,000 | +97.4% | 49,229,000 | +111.9% | 0.67% | +110.3% |
| Q4 2021 | $14,657,000 | -49.5% | 23,229,000 | +10.6% | 0.32% | -58.3% |
| Q3 2021 | $29,010,000 | -64.4% | 21,000,000 | -57.7% | 0.77% | -66.1% |
| Q2 2021 | $81,551,000 | -1.2% | 49,655,000 | 0.0% | 2.26% | -31.3% |
| Q1 2021 | $82,515,000 | – | 49,655,000 | – | 3.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 49,655,000 | $82,515,000 | 3.29% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 80,000,000 | $131,952,000 | 2.77% |
| Aequim Alternative Investments LP | 22,000,000 | $36,397,000 | 2.35% |
| WOLVERINE ASSET MANAGEMENT LLC | 66,696,000 | $110,306,000 | 0.93% |
| Polar Asset Management Partners Inc. | 50,000,000 | $82,872,000 | 0.82% |
| Castle Creek Arbitrage, LLC | 6,500,000 | $10,746,000 | 0.62% |
| Soleus Capital Management, L.P. | 1,950,000 | $3,216,000 | 0.58% |
| WESTWOOD HOLDINGS GROUP INC | 16,000,000 | $26,497,000 | 0.27% |
| Nicholas Investment Partners, LP | 2,100,000 | $3,464,000 | 0.24% |
| Magnetar Financial LLC | 14,500,000 | $24,028,000 | 0.23% |